226 related articles for article (PubMed ID: 20503149)
21. Zonisamide versus diazepam in the treatment of alcohol withdrawal syndrome.
Rubio G; López-Muñoz F; Ponce G; Pascual JM; Martínez-Gras I; Ferre F; Jiménez-Arriero MÁ; Alamo C
Pharmacopsychiatry; 2010 Nov; 43(7):257-62. PubMed ID: 20927698
[TBL] [Abstract][Full Text] [Related]
22. [Outpatient alcohol detoxification].
Scherle T; Croissant B; Heinz A; Mann K
Nervenarzt; 2003 Mar; 74(3):219-25. PubMed ID: 12627236
[TBL] [Abstract][Full Text] [Related]
23. Comparative effectiveness and costs of inpatient and outpatient detoxification of patients with mild-to-moderate alcohol withdrawal syndrome.
Hayashida M; Alterman AI; McLellan AT; O'Brien CP; Purtill JJ; Volpicelli JR; Raphaelson AH; Hall CP
N Engl J Med; 1989 Feb; 320(6):358-65. PubMed ID: 2913493
[TBL] [Abstract][Full Text] [Related]
24. The anticonvulsant levetiracetam potentiates alcohol consumption in non-treatment seeking alcohol abusers.
Mitchell JM; Grossman LE; Coker AR; Messing RO
J Clin Psychopharmacol; 2012 Apr; 32(2):269-72. PubMed ID: 22367657
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of an intensive outpatient rehabilitation program in alcoholism: predictors of outcome 6 months after treatment.
Bottlender M; Soyka M
Eur Addict Res; 2005; 11(3):132-7. PubMed ID: 15990430
[TBL] [Abstract][Full Text] [Related]
26. Impact of craving on alcohol relapse during, and 12 months following, outpatient treatment.
Bottlender M; Soyka M
Alcohol Alcohol; 2004; 39(4):357-61. PubMed ID: 15208171
[TBL] [Abstract][Full Text] [Related]
27. Divalproex sodium in alcohol withdrawal: a randomized double-blind placebo-controlled clinical trial.
Reoux JP; Saxon AJ; Malte CA; Baer JS; Sloan KL
Alcohol Clin Exp Res; 2001 Sep; 25(9):1324-9. PubMed ID: 11584152
[TBL] [Abstract][Full Text] [Related]
28. Acceptability and tolerability of levetiracetam oral solution for the treatment of partial-onset seizures: the SOLUCIÓN study.
Matías-Guíu J; Molins A; Mauri JA; Villar E
Methods Find Exp Clin Pharmacol; 2010 Sep; 32(7):507-16. PubMed ID: 21069102
[TBL] [Abstract][Full Text] [Related]
29. Neurocognitive effects of adjunctive levetiracetam in children with partial-onset seizures: a randomized, double-blind, placebo-controlled, noninferiority trial.
Levisohn PM; Mintz M; Hunter SJ; Yang H; Jones J;
Epilepsia; 2009 Nov; 50(11):2377-89. PubMed ID: 19702752
[TBL] [Abstract][Full Text] [Related]
30. Effects of levetiracetam on EEG abnormalities in juvenile myoclonic epilepsy.
Specchio N; Boero G; Michelucci R; Gambardella A; Giallonardo AT; Fattouch J; Di Bonaventura C; de Palo A; Ladogana M; Lamberti P; Vigevano F; La Neve A; Specchio LM
Epilepsia; 2008 Apr; 49(4):663-9. PubMed ID: 18266754
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of levetiracetam: a review of three pivotal clinical trials.
Privitera M
Epilepsia; 2001; 42 Suppl 4():31-5. PubMed ID: 11564123
[TBL] [Abstract][Full Text] [Related]
32. The effectiveness of telephone-based continuing care for alcohol and cocaine dependence: 24-month outcomes.
McKay JR; Lynch KG; Shepard DS; Pettinati HM
Arch Gen Psychiatry; 2005 Feb; 62(2):199-207. PubMed ID: 15699297
[TBL] [Abstract][Full Text] [Related]
33. Adjunctive levetiracetam in infants and young children with refractory partial-onset seizures.
Piña-Garza JE; Nordli DR; Rating D; Yang H; Schiemann-Delgado J; Duncan B;
Epilepsia; 2009 May; 50(5):1141-9. PubMed ID: 19243423
[TBL] [Abstract][Full Text] [Related]
34. Ability of baclofen in reducing alcohol craving and intake: II--Preliminary clinical evidence.
Addolorato G; Caputo F; Capristo E; Colombo G; Gessa GL; Gasbarrini G
Alcohol Clin Exp Res; 2000 Jan; 24(1):67-71. PubMed ID: 10656195
[TBL] [Abstract][Full Text] [Related]
35. Levetiracetam versus placebo in childhood and adolescent autism: a double-blind placebo-controlled study.
Wasserman S; Iyengar R; Chaplin WF; Watner D; Waldoks SE; Anagnostou E; Soorya L; Hollander E
Int Clin Psychopharmacol; 2006 Nov; 21(6):363-7. PubMed ID: 17012983
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and safety of levetiracetam in patients with glioma: a clinical prospective study.
Rosati A; Buttolo L; Stefini R; Todeschini A; Cenzato M; Padovani A
Arch Neurol; 2010 Mar; 67(3):343-6. PubMed ID: 20212232
[TBL] [Abstract][Full Text] [Related]
37. Kindling of withdrawal: a study of craving and anxiety after multiple detoxifications in alcoholic inpatients.
Duka T; Townshend JM; Collier K; Stephens DN
Alcohol Clin Exp Res; 2002 Jun; 26(6):785-95. PubMed ID: 12068246
[TBL] [Abstract][Full Text] [Related]
38. Levetiracetam for the treatment of alcohol withdrawal syndrome: an open-label pilot trial.
Krebs M; Leopold K; Richter C; Kienast T; Hinzpeter A; Heinz A; Schaefer M
J Clin Psychopharmacol; 2006 Jun; 26(3):347-9. PubMed ID: 16702910
[No Abstract] [Full Text] [Related]
39. Use of levetiracetam to treat tics in children and adolescents with Tourette syndrome.
Awaad Y; Michon AM; Minarik S
Mov Disord; 2005 Jun; 20(6):714-8. PubMed ID: 15704204
[TBL] [Abstract][Full Text] [Related]
40. Levetiracetam in the prophylaxis of migraine with aura: a 6-month open-label study.
Brighina F; Palermo A; Aloisio A; Francolini M; Giglia G; Fierro B
Clin Neuropharmacol; 2006; 29(6):338-42. PubMed ID: 17095897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
